Skip to main content
Stephen George headshot

Stephen George

Senior Consultant
Tampa, FL, US
Stephen is a senior healthcare consultant with the Tampa office of Milliman.
Download bioDownload

Experience

Stephen is a pharmacist with 20 years of experience. He serves as a senior consultant assisting clients in various areas including healthcare plan pharmacy operations, management of physician-administered and specialty drugs, integration of pharmacy and medical outcomes analysis, and developing ROI evaluations on medical interventions.

Stephen has experience in a variety of patient care and management settings—managed care, hospital, care management, and clinical trials. He has experience with health policy analysis, pharmacoeconomics and outcomes research, auditing PBM/specialty pharmacy contracts, 340-B pricing models, implementing disease management models, drug/device pricing, assessing pharmacy MTM programs, and developing "best in class" clinical applications.

Previous positions include:

  • VP and Partner Conexus Health
  • Pharmacy Advisor Hillsborough County Healthcare Plan
  • Pharmacy Director Physician Corporation of America
  • Clinical Pharmacist Mount Carmel Medical Center
He has published and presented numerous publications, posters, strategy sessions, and podium presentations. He has participated as co-investigator or lead research pharmacist in several Phase II – IV clinical trials.
Publications

Read their latest work

Article

A claims-based analysis of prostate biopsy episodes when there is no evidence of a cancer diagnosis

26 February 2024 - by Pamela Laboy, Carol Bazell, Stephen George, Keely Congdon, Jack Tyson
Our recent analysis shows how the total cost of care for prostate biopsy episodes varied substantially, based on whether the patient had complications.
Article

Exploring Medicare Part D prior authorizations

17 June 2020 - by Stephen George, Lisa Mattie
Prior authorization presents benefits and challenges along with opportunities for improvement as plan sponsors aim to control costs and ensure access to appropriate drugs.
Article

A review of vaccinations: A tool in battling viral infections

08 June 2020 - by Stephen George, Joel Brill
In view of the COVID-19 pandemic, this paper examines why, when, and how vaccines are used; highlights the vaccine development pathway; reviews previous experience with viral pandemics; and assesses ways payers can address COVID-19.
Article

Evaluation of the Appropriateness of EmpiRx’s Clinical Savings Tracker for Estimating Ingredient Cost Savings

19 November 2019 - by Stephen George, Tracy Margiott
This report provides an independent review of the processes EmpiRx Health uses to calculate savings under the Clinical Savings Tracker component of its Clinical Care Management program.
Article

Assessing the potential revenue impact to oncology practices under a cancer drug therapy bundled reimbursement model

20 March 2017 - by Stephen George, Stuart D. Rachlin
This report evaluates the potential impact to provider reimbursement under alternative oncology payment structures and illustrates the inherent variabilities across patients using a simplified alternative oncology payment bundle for cancer drug treatments and related professional services.